Latest news
Roche-backed Mironid gets $46M boost to put rare kidney disease drug on path to clinic - FirstWord PHARMAFirstWord PHARMA · Wed, 05 Aug 2026 08:06:57 GMTAstraZeneca, BMS reportedly in $400B merger talks - FirstWord PHARMAFirstWord PHARMA · Mon, 03 Aug 2026 04:16:55 GMTJ&J strikes CAR-T pact with Sail Bio, bags $2.58B buyout option - FirstWord PHARMAFirstWord PHARMA · Thu, 30 Jul 2026 12:26:36 GMT